May 3, 2018.
According to the French Association of Thyroid Patients (AFMT), the new formula of Levothyrox is not only guilty of causing unwanted side effects, it also contains metal nanoparticles.
Metal nanoparticles
A new episode is being written in this dark affair of Levothyrox. The Merck laboratory, which manufactures this drug for thyroid patients, changed the formula in 2017, without warning patients who, for some, experienced unwanted side effects. Excessive fatigue, headaches, dizziness, hair loss … In total, 1,200 patients have filed a complaint against the laboratory.
But this is likely to make matters even worse: during a press conference, Dr Jacques Guillet let it be known that he had analyzed the composition of the new drug, for the benefit of the French Association of Patients with thyroid, and that metal nanoparticles had been found there. ” Nanoparticles with iron-chromium, chromium-nickel, iron-chromium-silicon, ferrochrome-aluminum alloys are demonstrated. “, He noted.
Nanoparticles responsible for side effects?
According to him, in the old formula, “ there was only some scrap of steel “. In the process, the AFMT asked the judge in charge of the case to examine the possible role of these nanoparticles in the side effects felt by patients. This investigating judge is currently investigating the facts of aggravated deception, unintentional injury and endangerment of others.
“ It’s not about panicking people “, Tempered Dr Jacques Guillet. ” Nanoparticles, we inhale a lot more while walking in the streets of Paris “. For its part, the Merck laboratory was keen to respond to these accusations: “ Whether it is the old or the new formula, we remind you that the analysis of all heavy metals was carried out in accordance with the regulations in force, and we reaffirm that all of these checks were found to be within specification “. To be continued…
Marine Rondot
Read also: Nanoparticles in Efferalgan and Spasfon
